[HTML][HTML] Glucocorticoids—all-rounders tackling the versatile players of the immune system

C Strehl, L Ehlers, T Gaber, F Buttgereit - Frontiers in immunology, 2019 - frontiersin.org
Glucocorticoids regulate fundamental processes of the human body and control cellular
functions such as cell metabolism, growth, differentiation, and apoptosis. Moreover …

Targeting transcription factors in cancer

AS Bhagwat, CR Vakoc - Trends in cancer, 2015 - cell.com
Transcription factors (TFs) are commonly deregulated in the pathogenesis of human cancer
and are a major class of cancer cell dependencies. Consequently, targeting of TFs can be …

Glucocorticoids and cancer

MA Pufall - Glucocorticoid Signaling: From Molecules to Mice to …, 2015 - Springer
Unlike other steroid hormone receptors, the glucocorticoid receptor (GR) is not considered
an oncogene. In breast cancer, the estrogen receptor (ER) drives cell growth, proliferation …

[HTML][HTML] Regulation of Bim in health and disease

RV Sionov, SA Vlahopoulos, Z Granot - Oncotarget, 2015 - ncbi.nlm.nih.gov
The BH3-only Bim protein is a major determinant for initiating the intrinsic apoptotic pathway
under both physiological and pathophysiological conditions. Tight regulation of its …

[HTML][HTML] JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias

C Delgado-Martin, LK Meyer, BJ Huang, KA Shimano… - Leukemia, 2017 - nature.com
While outcomes for children with T-cell acute lymphoblastic leukemia (T-ALL) have
improved dramatically, survival rates for patients with relapsed/refractory disease remain …

JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation

LK Meyer, KC Verbist, S Albeituni… - Blood, The Journal …, 2020 - ashpublications.org
Cytokine storm syndromes (CSS) are severe hyperinflammatory conditions characterized by
excessive immune system activation leading to organ damage and death. Hemophagocytic …

Dexamethasone treatment promotes Bcl-2 dependence in multiple myeloma resulting in sensitivity to venetoclax

SM Matulis, VA Gupta, AK Nooka, HV Hollen… - Leukemia, 2016 - nature.com
Abstract Venetoclax (ABT-199), a specific inhibitor of the anti-apoptotic protein Bcl-2, is
currently in phase I clinical trials for multiple myeloma. The results suggest that venetoclax is …

[HTML][HTML] IL-7 receptor mutations and steroid resistance in pediatric T cell acute lymphoblastic leukemia: a genome sequencing study

Y Li, JG Buijs-Gladdines, K Canté-Barrett… - PLoS …, 2016 - journals.plos.org
Background Pediatric acute lymphoblastic leukemia (ALL) is the most common childhood
cancer and the leading cause of cancer-related mortality in children. T cell ALL (T-ALL) …

MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance

JCG van der Zwet, JG Buijs-Gladdines, V Cordo'… - Leukemia, 2021 - nature.com
Abstract (Patho-) physiological activation of the IL7-receptor (IL7R) signaling contributes to
steroid resistance in pediatric T-cell acute lymphoblastic leukemia (T-ALL). Here, we show …

[HTML][HTML] Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia

J Sarno, P Domizi, Y Liu, M Merchant… - Nature …, 2023 - nature.com
Resistance to glucocorticoids (GC) is associated with an increased risk of relapse in B-cell
progenitor acute lymphoblastic leukemia (BCP-ALL). Performing transcriptomic and single …